Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT: NCT06827990 · RECRUITING

NCT IDNCT06827990
StatusRECRUITING
Start Date2025-09-22
Completion2031-09-01
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑